# A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients

Source: https://onco.cc/trials/nct06493760/  
OnCo record `nct06493760` (Trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

A phase 2 trial of PF-08634404, Bevacizumab, CAPOX in colorectal cancer, run by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., now recruiting.

## Summary

A Phase 2 Study of SSGJ-707 in Metastatic Colorectal Cancer Patients is a phase 2 interventional study registered as NCT06493760 by Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd., with 130 participants planned, started 2024-09-03 and due to reach its primary completion in 2025-06. Interventions recorded: SSGJ-707, Bevacizumab, Oxaliplatin, Capecitabine, Calcium Folinate. Conditions listed: Metastatic Colorectal Cancer. No results are recorded here; the registry entry is the source.

## Fields

- Kind: Trial
- Status: recruiting
- Last checked: 2026-09-16
- Tags: ctgov-ingest
- Registry id: NCT06493760
- Phase: 2
- Setting: A Phase 2 Study to Evaluate the Safety and Efficacy of SSGJ-707 As First-Line Treatment in Metastatic Colorectal Cancer Patients
- Sponsor: Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd.
- Enrolled: 130

## Sources

- ClinicalTrials.gov NCT06493760: https://clinicaltrials.gov/study/NCT06493760

## Connected records

- cancers: [Colorectal cancer](https://onco.cc/cancers/colorectal/)
- drugs: [Bevacizumab](https://onco.cc/drugs/bevacizumab/), [Capecitabine](https://onco.cc/drugs/capecitabine/), [CAPOX (capecitabine, oxaliplatin)](https://onco.cc/drugs/capox/), [Leucovorin (folinic acid)](https://onco.cc/drugs/leucovorin/), [PF-08634404](https://onco.cc/drugs/pf-08634404/)

---
JSON: https://onco.cc/api/v1/entities/nct06493760.json